MCID: PRS009
MIFTS: 23

Prostate Stromal Sarcoma malady

Categories: Cancer diseases, Reproductive diseases

Aliases & Classifications for Prostate Stromal Sarcoma

Aliases & Descriptions for Prostate Stromal Sarcoma:

Name: Prostate Stromal Sarcoma 12 14 69
Stromal Sarcoma of the Prostate 12

Classifications:



External Ids:

Disease Ontology 12 DOID:7152
NCIt 47 C5524
UMLS 69 C1335521

Summaries for Prostate Stromal Sarcoma

Disease Ontology : 12 A stromal sarcoma and sarcoma of prostate and tumor of specialized prostatic stroma that is located in the prostate.

MalaCards based summary : Prostate Stromal Sarcoma, also known as stromal sarcoma of the prostate, is related to anal buschke-lowenstein tumor and paranasal sinus disease. An important gene associated with Prostate Stromal Sarcoma is PGR (Progesterone Receptor). The drugs Morphine and Methylphenidate have been mentioned in the context of this disorder. Affiliated tissues include prostate and the prostate, and related phenotype is neoplasm.

Related Diseases for Prostate Stromal Sarcoma

Graphical network of the top 20 diseases related to Prostate Stromal Sarcoma:



Diseases related to Prostate Stromal Sarcoma

Symptoms & Phenotypes for Prostate Stromal Sarcoma

MGI Mouse Phenotypes related to Prostate Stromal Sarcoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 8.62 CD34 PGR

Drugs & Therapeutics for Prostate Stromal Sarcoma

Drugs for Prostate Stromal Sarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 41)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Morphine Approved, Investigational Phase 3 57-27-2 5288826
2
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
3
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
4 pancreatic polypeptide Phase 3
5 Epoetin alfa Phase 3 113427-24-0
6 Analgesics Phase 3
7 Adjuvants, Anesthesia Phase 3
8 Narcotics Phase 3
9 Analgesics, Opioid Phase 3
10 Anesthetics Phase 3
11 Anesthetics, General Phase 3
12 Anesthetics, Intravenous Phase 3
13 Peripheral Nervous System Agents Phase 3
14 Liver Extracts Phase 3,Phase 1
15 Central Nervous System Depressants Phase 3
16 Cola Nutraceutical Phase 3,Phase 1,Phase 2
17
Docetaxel Approved May 1996, Investigational Phase 1, Phase 2 114977-28-5 148124 9877265
18 Imatinib Mesylate Phase 2 123596
19 Androgens Phase 1, Phase 2
20 Protein Kinase Inhibitors Phase 2,Phase 1
21 tyrosine Nutraceutical Phase 2
22
Irinotecan Approved, Investigational Phase 1 97682-44-5, 100286-90-6 60838
23
Gemcitabine Approved Phase 1 95058-81-4 60750
24
Capecitabine Approved, Investigational Phase 1 154361-50-9 60953
25
Lenograstim Approved Phase 1 135968-09-1
26
Vorinostat Approved, Investigational Phase 1 149647-78-9 5311
27
Camptothecin Experimental Phase 1 7689-03-4
28
7-hydroxystaurosporine Experimental Phase 1 112953-11-4 72271
29 Staurosporine Experimental Phase 1 62996-74-1
30 topoisomerase I inhibitors Phase 1
31 Adjuvants, Immunologic Phase 1
32 Topoisomerase Inhibitors Phase 1
33 Histone Deacetylase Inhibitors Phase 1
34 Vaccines Phase 1
35 Anti-Infective Agents Phase 1
36 Immunosuppressive Agents Phase 1
37 Antimetabolites Phase 1
38 Antimetabolites, Antineoplastic Phase 1
39 Antimitotic Agents Phase 1
40 Antineoplastic Agents, Phytogenic Phase 1
41 Antiviral Agents Phase 1

Interventional clinical trials:

(show all 19)
id Name Status NCT ID Phase
1 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
2 E-MOSAIC Electronic Tool to Monitor Symptoms Completed NCT00477919 Phase 3
3 Chemotherapy in Treating Patients With Solid Tumors Completed NCT00003103 Phase 1, Phase 2
4 Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes Completed NCT00171912 Phase 2
5 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) Completed NCT00031681 Phase 1
6 Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors Completed NCT00014456 Phase 1
7 Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer Completed NCT00004065 Phase 1
8 A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen Completed NCT00623831 Phase 1
9 Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer Completed NCT00003704 Phase 1
10 Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor Completed NCT00161187 Phase 1
11 Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Completed NCT00083213 Phase 1
12 Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Completed NCT00082823 Phase 1
13 Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer Completed NCT00045006 Phase 1
14 Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer Unknown status NCT00601406
15 Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors Completed NCT00433602
16 B-Receptor Signaling in Cardiomyopathy Completed NCT01135849
17 Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients Completed NCT00253383
18 Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer Completed NCT00253708
19 Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors Withdrawn NCT00499291

Search NIH Clinical Center for Prostate Stromal Sarcoma

Genetic Tests for Prostate Stromal Sarcoma

Anatomical Context for Prostate Stromal Sarcoma

MalaCards organs/tissues related to Prostate Stromal Sarcoma:

39
Prostate

The Foundational Model of Anatomy Ontology organs/tissues related to Prostate Stromal Sarcoma:

18
The Prostate

Publications for Prostate Stromal Sarcoma

Articles related to Prostate Stromal Sarcoma:

id Title Authors Year
1
Synchronous prostate stromal sarcoma and gastrointestinal stromal tumor of rectum: case report and review of the literature. ( 16979698 )
2006
2
Prostatic stromal sarcoma: case report and review of the literature. ( 12787317 )
2003

Variations for Prostate Stromal Sarcoma

Expression for Prostate Stromal Sarcoma

Search GEO for disease gene expression data for Prostate Stromal Sarcoma.

Pathways for Prostate Stromal Sarcoma

GO Terms for Prostate Stromal Sarcoma

Biological processes related to Prostate Stromal Sarcoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 negative regulation of gene expression GO:0010629 8.96 CD34 PGR
2 paracrine signaling GO:0038001 8.62 CD34 PGR

Sources for Prostate Stromal Sarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....